Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02818036Completed
Randomised, double-blind trial of naltrexone. Primary endpoints: Blood Oxygen-Level Dependent Activations at 1 hour and Self-reported Feelings of Connection at 2 hours. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02818036.